Ian Frank Scholes

Vorstandsvorsitzender bei Chord Capital Pty Ltd.

Vermögen: 361 772 $ am 31.05.2024

69 Jahre

40 Beziehungen

Health Technology

Finance

Health Services

Aktive Positionen von Ian Frank Scholes

Unternehmen	Position	Beginn	Ende
Chord Capital Pty Ltd.	Vorstandsvorsitzender	-	-

Karriereverlauf von Ian Frank Scholes

Ehemalige bekannte Positionen von Ian Frank Scholes

Unternehmen	Position	Beginn	Ende
MAYNE PHARMA GROUP LIMITED	Direktor/Vorstandsmitglied	17.10.2007	30.09.2022
MAYNE PHARMA GROUP LIMITED	Independent Dir/Board Member	17.10.2007	30.09.2022
SDI LIMITED	Direktor/Vorstandsmitglied	06.07.2012	02.08.2013
SDI LIMITED	Independent Dir/Board Member	06.07.2012	02.08.2013
Halcygen Pharmaceuticals Ltd. Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia.	Direktor/Vorstandsmitglied	26.10.2009	22.11.2010
Merrill Lynch (Australia) Pty Ltd. Merrill Lynch (Australia) Pty Ltd. Financial ConglomeratesFinance Part of Bank of America Corp., Merrill Lynch (Australia) Pty Ltd. is an Australian company that provides online lease financing services. The company is based in Sydney, Australia.	Corporate Officer/Principal	29.11.2010	-
St. Vincent Health, Inc. St. Vincent Health, Inc. Hospital/Nursing ManagementHealth Services St. Vincent Health, Inc. is a non-profit organization which operates general hospitals and specialty hospitals. The company is headquartered in Indianapolis, IN.	Direktor/Vorstandsmitglied	25.11.2010	-
NATIONAL AUSTRALIA BANK LIMITED	Corporate Officer/Principal	-	-

Ausbildung von Ian Frank Scholes

University of Melbourne

Undergraduate Degree

Statistik

International

Australien	8
Vereinigte Staaten	2

Operativ

Director/Board Member	4
Independent Dir/Board Member	2
Corporate Officer/Principal	2

Sektoral

Health Technology	4
Finance	3
Health Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	3
MAYNE PHARMA GROUP LIMITED	Health Technology
NATIONAL AUSTRALIA BANK LIMITED	Finance
SDI LIMITED	Health Technology

Private Unternehmen	4
Halcygen Pharmaceuticals Ltd. Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia.	Health Technology
St. Vincent Health, Inc. St. Vincent Health, Inc. Hospital/Nursing ManagementHealth Services St. Vincent Health, Inc. is a non-profit organization which operates general hospitals and specialty hospitals. The company is headquartered in Indianapolis, IN.	Health Services
Merrill Lynch (Australia) Pty Ltd. Merrill Lynch (Australia) Pty Ltd. Financial ConglomeratesFinance Part of Bank of America Corp., Merrill Lynch (Australia) Pty Ltd. is an Australian company that provides online lease financing services. The company is based in Sydney, Australia.	Finance
Chord Capital Pty Ltd.

Sehen Sie sich die Unternehmensverbindungen an